270 related articles for article (PubMed ID: 26714242)
21. Effects of colchicine on risk of cardiovascular events among patients with gout: as evidence accrues, is it time for a randomised trial?
Giannopoulos G; Deftereos S
Ann Rheum Dis; 2016 May; 75(5):e28. PubMed ID: 26893488
[No Abstract] [Full Text] [Related]
22. Hazards of colchicine.
Jones WN; Maricic MJ
Am J Health Syst Pharm; 2005 Jul; 62(13):1350; author reply 1350. PubMed ID: 15972374
[No Abstract] [Full Text] [Related]
23. Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: the effect of index date selection?
Nielen JT; Oshagbemi O; de Vries F; Burden AM
Ann Rheum Dis; 2016 May; 75(5):e26. PubMed ID: 26873268
[No Abstract] [Full Text] [Related]
24. [Aspects of colchicine therapy. 1: Pharmacology, toxicology, classic indications].
Lange U; Schumann C; Schmidt KL
Z Arztl Fortbild Qualitatssich; 2002 Jan; 96(1):59-63. PubMed ID: 11876051
[TBL] [Abstract][Full Text] [Related]
25. Colchicine and other drugs for gout.
Med Lett Drugs Ther; 2009 Nov; 51(1326):93-4. PubMed ID: 20224523
[No Abstract] [Full Text] [Related]
26. [Colchicine treatment of a pregnant woman with familial Mediterranean fever].
Duer A; Hansen A
Ugeskr Laeger; 2005 Jan; 167(2):183-4. PubMed ID: 15697133
[No Abstract] [Full Text] [Related]
27. Patient awareness, knowledge and use of colchicine: an exploratory qualitative study in the Counties Manukau region, Auckland, New Zealand.
Rebello C; Thomson M; Bassett-Clarke D; Martini N
J Prim Health Care; 2016 Jun; 8(2):140-8. PubMed ID: 27477556
[TBL] [Abstract][Full Text] [Related]
28. Use of intravenous colchicine in patients with acute gout.
Stephan WH
Am Fam Physician; 2000 Apr; 61(8):2343-4. PubMed ID: 10794578
[No Abstract] [Full Text] [Related]
29. Colchicine--what is its place in the management of acute gout?
Winzenberg T; Zochling J
Aust Fam Physician; 2007 Jul; 36(7):529-30. PubMed ID: 17619668
[TBL] [Abstract][Full Text] [Related]
30. Colchicine in Gout: An Update.
Pascart T; Richette P
Curr Pharm Des; 2018; 24(6):684-689. PubMed ID: 29336252
[TBL] [Abstract][Full Text] [Related]
31. Opportunities for improving medication use and monitoring in gout.
Singh JA; Hodges JS; Asch SM
Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
[TBL] [Abstract][Full Text] [Related]
32. [Spectacular efficacy of colchicine in a beginning cardiac tamponade].
Bire F; Nicolas X; André M; Gut-Gobert C; Natali F; Bergez C
Presse Med; 2002 Mar; 31(8):359. PubMed ID: 11913079
[No Abstract] [Full Text] [Related]
33. Effective management of gout.
Weinstein J
Am J Med; 1999 Oct; 107(4):406. PubMed ID: 10527052
[No Abstract] [Full Text] [Related]
34. Colchicine in acute gout.
Morris I; Varughese G; Mattingly P
BMJ; 2003 Nov; 327(7426):1275-6. PubMed ID: 14644973
[No Abstract] [Full Text] [Related]
35. Gout. Aspects of management.
Hepburn AL; Rider TG; Jordan KM
BMJ; 2011 Jan; 342():d115. PubMed ID: 21224313
[No Abstract] [Full Text] [Related]
36. An evidence based appraisal of the management of nontophaceous interval gout.
Ferraz MB
J Rheumatol; 1995 Sep; 22(9):1618-9. PubMed ID: 8523332
[No Abstract] [Full Text] [Related]
37. [Hyperuricemia/gout. Main symptoms of arthropathy. Severe acute joint pain, redness, inflammation].
Kolyvanos Naumann U; Suter PM; Käser L; Vetter W
Praxis (Bern 1994); 2005 Apr; 94(14):543-8; quiz 549. PubMed ID: 15849976
[No Abstract] [Full Text] [Related]
38. Advances in the proper use of colchicine and adapting dosages in other countries: comment on the article by Terkeltaub et al.
Lioté F
Arthritis Rheum; 2010 Oct; 62(10):3126-7; author reply 3127-8. PubMed ID: 20617519
[No Abstract] [Full Text] [Related]
39. Colchicine: time to rethink.
Varughese GI; Varghese AI; Tahrani AA
N Z Med J; 2007 Feb; 120(1249):U2429. PubMed ID: 17308565
[No Abstract] [Full Text] [Related]
40. [Gout: diagnosis and therapy].
Schlapbach P
Ther Umsch; 1985 Oct; 42(10):687-90. PubMed ID: 3909489
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
